Description
Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
Article: Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
€3.03
€3.03
Caplacizumab, a game changer in the treatment of acquired thrombotic thrombocytopenic purpura
Top
Notifications
